Next Article in Journal
Bicuspid Aortic Valve and Premature Ventricular Beats in Athletes
Next Article in Special Issue
Study Protocol of “Sustainably Healthy—From Science 2 Highschool & University”—Prevalence of Mixed, Vegetarian, and Vegan Diets Linked to Sports & Exercise among Austrian Tertiary Students and Lecturers/Academic Staff
Previous Article in Journal
A Dyadic Pain Management Program for Community-Dwelling Older Adults with Chronic Pain: Study Protocol for a Cluster Randomized Controlled Trial
Previous Article in Special Issue
Self-Learning about Herbal and Dietary Supplements: Perspectives Using the Theoretical Domains Framework
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJERPH
Volume 19
Issue 19
10.3390/ijerph191912187
ijerph-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Micronutrients and the Risk of Allergic Diseases in School Children

by
Daniela Podlecka
1,
Joanna Jerzyńska
1,*,
Khadijah Sanad
2,
Kinga Polańska
1,3,
Monika Bobrowska-Korzeniowska
1,
Iwona Stelmach
4 and
Agnieszka Brzozowska
1
1
Department of Pediatrics and Allergy, Medical University of Lodz, 90-328 Lodz, Poland
2
Medical University of Lodz, 90-124 Lodz, Poland
3
Department of Environmental and Occupational Health Hazards, Nofer Institute of Occupational Medicine, 91-324 Lodz, Poland
4
Poddębice Health Care Centre, 99-200 Poddębice, Poland
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2022, 19(19), 12187; https://doi.org/10.3390/ijerph191912187
Submission received: 13 August 2022 / Revised: 21 September 2022 / Accepted: 22 September 2022 / Published: 26 September 2022
(This article belongs to the Special Issue Nutrition, Diet and Public Health: Assessment in Different Individuals and Groups)
Review Reports Versions Notes

Abstract

:
Microelements and vitamins are believed to have immunomodulatory effects. The aim of the study was to establish the role of antioxidants (vitamins A, E, D) and microelements such as copper (Cu), selenium (Se), and zinc (Zn) levels in allergic diseases in schoolchildren. The study uses a cohort of 80 children (40 with and 40 without allergy/asthma diagnosis) aged 9 to 12 years recruited for the Polish Mother and Child Cohort Study. At nine to twelve years old, the children were tested for microelement and vitamin content and health status (including skin-prick test and spirometry, urine cotinine level). Demographic data were collected from mothers by an allergist. The risk of asthma occurrence was found to be significantly related to the levels of Cu and Zn. The level of Cu was also particularly closely associated with allergic rhinitis and was indicated as a significant predictor of food allergy. The levels of Cu and Zn, and poor nutritional status in general, can influence the immune system and may be considered risk factors for developing asthma, allergic rhinitis and food allergy.

1. Introduction

Recent years have seen increasing interest in the role of nutrition in the development of allergic diseases. Essential micronutrients (microelements and vitamins), which are believed to have an immunomodulatory effect, have become a particular object of interest. An antioxidant is a substance that protects cells from the damage caused by free radicals: unstable molecules produced by oxidation during normal metabolism [1], and which can play a part in cancer, heart disease, stroke, and various aging-related diseases. The most commonly known antioxidants include beta-carotene, lycopene, vitamins A, C, E. An essential microelement is an element such as chromium, copper, cobalt, iodine, iron, selenium and zinc, which is present in the human body in very small amounts, but is important to health [2]. These microelements play a crucial role in the development of allergic diseases such as asthma and atopic dermatitis in children [1,2]. For example, vitamin E influences the development of wheezing and asthma in children [3]. Many studies have shown a relationship between serum 25-hydroxyvitamin D (25(OH)D) level, and Scoring Atopic Dermatitis (SCORAD) index or Eczema Area and Severity Index (EASI) score severity [4]. It has also been suggested that atopic children with low vitamin D serum levels have benefited from vitamin supplementation.
However, there is a lack of clear evidence in the available literature regarding the relationship between serum vitamin A and E levels and the risk of developing allergic diseases; in addition, 25-hydroxyvitamin D is inversely associated with wheezing, especially those caused by a viral infection [5]. Imbalances in vitamin and essential mineral levels can disturb immunity and may result in immunodeficiency [6], manifesting in allergic diseases such as urticaria, atopic disease, and asthma [6,7].
The results of our previous studies of the data from the Polish Mother and Child Cohort study (REPRO_PL cohort) indicate that the levels of essential microelements in the umbilical cord are related to the chance of developing allergic disease in children [8]. More specifically, higher levels of copper and zinc in the blood are associated with a greater likelihood of developing wheezing early in life [7]. In addition, a high level of copper concentration in cord blood predisposed children to allergic rhinitis and atopic dermatitis, while a low level was observed in those with asthma. Another study found low zinc concentration in umbilical cord blood in children with allergic rhinitis ages 7–9 years old [9].
The present study aims to establish the role of antioxidants such as vitamin A, D, E and essential microelements such as copper, selenium and zinc in the development of allergic diseases in children aged 9–12 years old from the previously formed REPRO_PL cohort.

2. Materials and Methods

2.1. Study Design and Participants

The Polish Mother and Child Cohort (REPRO_PL) was established in 2007 [8,9,10]. The recruitment process and follow-up procedures, together with a complete description of the methodological assumptions, have been published elsewhere [11,12]. Briefly, the mothers were recruited during the first trimester of pregnancy at maternity units or clinics in two regions of Poland (Lodz and Legnica) if they fulfilled the following inclusion criteria: single pregnancy up to 12 weeks of gestation, no assisted conception, no pregnancy complications, and no chronic diseases as specified in the study protocol [8]. Between nine and twelve years after the birth, an invitation letter was sent to mothers with an invitation to participate in follow-up examinations covering exposure (including questionnaire data) and an assessment of the child’s health status. Parents were also interviewed to collect demographic and socioeconomic data, medical and reproductive history. The current analysis is restricted to 80 children (40 with allergy/asthma diagnosis and 40 without allergy/asthma diagnosis) children between the ages of 9 and 12 years. All mothers gave their written consent to take part before the follow–up study. Approval was given by the Ethical Committee of the Nofer Institute of Occupational Medicine, Lodz, Poland (Decision No. 7/2007, 3/2008, and 22/2014), for the primary study and by the Medical Ethics Committee of the Medical University of Lodz (Decision No. RNN/388/17/KE) for the follow–up study.

2.2. Child Health Assessment

Health status was assessed in children between 9 and 12 years of age; briefly, a questionnaire was administered to the mothers, and this was supplemented with information from the medical chart of each child. A clinical examination was also performed by a pediatrician/allergist in the presence of the mother or a relative. This part of the questionnaire has been developed by an allergist, based on recommendations from the International Study of Asthma and Allergies in Childhood (ISAAC) and has been applied previously [13,14]. In addition, the occurrence of allergy among family members was noted. Patients were defined as having asthma, allergic rhinitis, or atopic dermatitis if they had ever been diagnosed by a physician; asthma was diagnosed based on GINA guidelines.
Patients underwent spirometry and skin prick tests (SPT), or specific IgE where it was not possible to perform the SPT. Detailed information on the methods employed is given elsewhere [15]. Urine cotinine level was also measured as a marker of tobacco smoke exposure. The following history data from the questionnaire were considered: breastfeeding, dampness, having pets at home, and present urine cotinine level.

2.3. Allergen Sensitization

Skin prick testing was performed using standard allergen extracts from Allergopharma (Reinbek, Germany). A reaction >3 mm in diameter above the negative control recorded at 15 min were considered positive.
Allergen sensitization was defined as specific IgE of ≥0.35 KU/L for at least one of tested allergens (chemiluminescence method (CLIA), Immulite 2000, XPI, Siemens, Munich, Germany).

2.4. Lung Function, Body Plethysmography (sRtot, Rocc)

All pulmonary function tests were performed with a Master Screen unit (Erich Jaeger Gmbh-Hochberg, Friedberg, Germany), as described elsewhere, in accordance with the ATS/ERS guidelines [16].

2.5. Plasma Copper and Zinc Concentrations

Plasma copper and zinc concentrations were analyzed by flame atomic absorption [17]. These methods were validated using lyophilized human reference serum samples of Seronorm from Nycomed Pharma AS (Oslo, Norway) as reference material, and through participation in interlaboratory comparison trials.

2.6. Plasma Selenium Concentrations

Plasma Se concentration was measured by graphite furnace atomic absorption spectrometry (GFAAS) on an Unicam Solar 989 QZ (Institute for Reference Materials and Measurements attn, CRM Sales Retieseweg 111, B-2440 Geel, Belgium) apparatus according to Nève et al. [18] with modifications. The accuracy of the method was verified by using internal quality control of the certified reference material BCR-637 (IRMM, Geel, Belgium), whose reference value and measured concentration were 81.0 µg/L (in the range 74–88 µg/L) and 82.5 ± 0.7 µg/L, respectively.

2.7. Vitamin D, E and A Levels

Blood vitamin D, E and A levels were determined by an HPLC system integrated with UV-VIS detector range 190–800 nm [19,20].
The only vitamin D metabolite used to determine whether a patient is vitamin D deficient, sufficient or intoxicated is 25(OH)D. The obtained 25(OH)D level represents a summation of both vitamin D intake and vitamin D produced by sun exposure. In addition, 1,25-hydroxyvitamin D is the biologically active form of vitamin D. Therefore, the study examined the correlation between these two metabolites (Vit D 1,25 and Vit D25) and allergic status: all identified correlations for both metabolites are presented in the tables.

2.8. Cotinine Level Assessment

A urine sample was collected from all patients. A 50 mL volume of morning urine from children was collected into a 100 mL polypropylene container (Bene, Poland). All urine samples were transported to the laboratory in a cool box and stored at −20 °C until analysis. Urinary cotinine levels in ng/mL (marker of tobacco smoke exposure) were determined according to Stragierowicz et al. [21].

2.9. Statistical Analysis

Statistical analysis was carried out using R software, version 4.0.5. Nominal variables are presented as counts (n) with % of group, and continuous variables as arithmetic mean ± standard deviation. The distribution was determined based on the Shapiro–Wilk test and skewness and kurtosis values. The Zn, Se, Cu, vitamin D, vitamin A and vitamin E levels were compared between groups with the independent t-test. Their impact on the presence of allergies and allergic diseases was determined using logistic regression models. Separate models were prepared using the various allergy and allergic disease as dependent variables, with levels of Zn, Se, Cu, vitamin D, vitamin A and vitamin E as independent variables. Both unadjusted and adjusted models were created. To avoid overfitting due to too many variables, considering the sample size, only three covariates were selected for the adjusted models: mother’s age, mother’s education, income. No correction for pets or breastfeeding was needed since all patients had pets and were breastfed.
Additionally, correlation between FEV1 (Forced Vital Capacity in 1st second) and level of Zn, Se, Cu, vitamin D, vitamin A and vitamin E was verified with Pearson’s correlation coefficient. All analyses were based on significance level of 0.05.

3. Results

The characteristics of the study group are presented in Table 1. The mean blood concentrations of Zn, Se, Cu, vitamin D, vitamin A, and vitamin E in the case of asthma, allergic rhinitis, atopic dermatitis, food allergy, and HDM allergy are presented in Table 2.

3.1. Asthma

The logistic regression found that the risk of asthma was significantly related to the level of Cu, as based on an unadjusted model, OR = 0.97 CI 95% [0.95–0.99], p = 0.043. This relationship was not, however, confirmed after adjustment for covariates. The Zn level also impacted the occurrence of asthma, both in unadjusted and adjusted models, OR = 1.04 CI 95% [1.01–1.08], p = 0.034 for adjusted model, Table 3. Patients with asthma had a significantly higher level of Zn (p = 0.029) and a lower level of Cu (p = 0.039) than patients without asthma, Table 2.

3.2. Allergic Rhinitis (AR)

The risk of AR was significantly related to the level of Cu, as based on unadjusted model, OR = 0.97 CI 95% [0.94–0.99], p = 0.031. This relationship was not confirmed after considering covariates. Patients with AR had a significantly higher level of Zn (p = 0.045) and a lower level of Cu (p = 0.027) than patients without AR (Table 2).

3.3. Atopic Dermatitis (AD)

The logistic regression analyses indicate that AD development does not appear to be influenced by any of the tested parameters (Zn, Se, Cu, vitamin D, vitamin A and vitamin E).

3.4. Food Allergy

The logistic regression confirmed that Cu was a significant predictor of food allergy, both in the unadjusted and adjusted models, OR = 1.05 CI 95% [1.01–1.11], p = 0.020 for the latter. Patients with food allergy demonstrated a significantly higher Cu level than patients without (p = 0.009), Table 3.

3.5. Lung Function

No significant correlation was found between FEV1 and levels of Zn, Se, Cu, vitamin D, vitamin A and vitamin E (p > 0.05 in all cases). Table 4.

4. Discussion

The essential micronutrients Cu and Zn or Se have a complex influence on the immune system and it is difficult identify a specific pro-allergic mechanism. There is wide evidence that allergic disorders, such as asthma, rhinitis and atopic dermatitis, are mediated by oxidative stress. Copper is an essential transition metal that could play an important role in redox reactions, while zinc concentration has a potent immunomodulatory capacity, particularly influencing T helper cell organization and cytokine secretion. Deficiencies of the nutrients selenium (Se), zinc (Zn), and vitamins A, C, D, and E may be associated with the development of asthma and allergic disorders [9]. Our findings indicate that the risk of asthma is significantly related to the level of Cu, according to an unadjusted model, and that the level of Zn also influences the occurrence of asthma, in both unadjusted and adjusted models. What is more, the concentration of Cu was significantly related to AR and appears to be a strong predictor of food allergy. In our group no significant correlations were found between vitamin levels (A, E, D) and allergic status and spirometry parameters.
Micronutrients are often obtained from food, and are essential for the healthy development of the body and disease prevention [22,23]. Among these, zinc, selenium, and copper are known to play important roles in maintaining health; however, all micronutrients have a significant impact on the functioning of the immune system [23,24]. Currently, supplementation of zinc or selenium in addition to food sources is recommended for well-being [25].
It is known that both copper deficiency and excess can lead to chronic inflammation [25,26]. Our findings indicate that Cu and Zn are both important components in the development of some allergic conditions, such as asthma, allergic rhinitis and food allergy, but not with atopic dermatitis. No differences were observed with regard to the intake of selenium or the vitamins; however, the study did not evaluate the children’s diet or supplementation by individual nutrients. Hu states that increased selenium levels are associated with a reduced prevalence of asthma and increased lung function [27].
Seaton et al. propose that the population has become more susceptible to asthma due to reduced antioxidant intake [28]. It has also been supposed that the lower intake of antioxidants and microelements might affect the first interaction between antigens and the immune system [29,30]. Another study found that maternal zinc intake during pregnancy was negatively associated with asthma ever diagnosed or active asthma [13], and patients with recurrent wheezing and a positive Asthma Predictive Index were found to have significantly lower vitamin D levels, and significantly higher serum zinc and copper concentrations [31]. It has also been postulated that the serum level of vitamin D, copper and zinc can be used as a routine biomarker for asthma risk in patients with recurrent wheezing alongside the Asthma Predictive Index and temporal pattern of wheeze [31].
However, these findings are not confirmed by our present results. It is possible that the increase in serum Zn in our study might cause a reduction in serum Cu, resulting in greater inflammation by decreasing the capacity of the antioxidant system. Other trials have failed to show any differences between children with asthma and healthy children in terms of Cu and Zn level [32].
The two main sources of dietary vitamin A are provitamin A carotenoids and retinol, which are mainly found in red and orange fruits [33,34]. Vitamin A is considered to be strong lipid-soluble antioxidant [33]. Gilliland et al. found a correlation between vitamin A, improved lung function and lower asthma incidence [35]. In addition, the increased risk of asthma was been found to be associated with lower serum carotenoid levels, including those of vitamin A precursors (α-carotene, β-carotene and β-cryptoxanthin), but not with the serum vitamin A concentration [36]. In a murine model of vitamin deficiency, vitamin A is linked with abnormal accumulation of airway smooth muscle and inflammation in lungs [34]. Unfortunately, human studies did not identify any relationship between serum vitamin A concentration and the development of asthma and allergic diseases in children and adults [37,38]. Furthermore, vitamin A supplementation was not found to have any significant effect in preventing early life childhood atopy up to an age of seven years in a randomized controlled trial [39]. This is consistent with our findings in a similar-aged population.
The influence of vitamin D on allergic conditions has been widely investigated in the past decade and the findings suggest great potential in achieving asthma control. In a recent meta-analysis, fourteen studies demonstrated that vitamin D supplementation for the management of asthma was associated with a lower rate of exacerbation, but that it would be helpful only in patients with bronchial asthma with vitamin D insufficiency at baseline (vitamin D insufficiency defined as a concentration in plasma less than 20 ng/mL) [40]. The same meta-analysis found FEV1% improvement in patients with air limitations to be associated with and vitamin D insufficiency [41]. Vitamin D supplementation has also been found to be associated with a lower rate of exacerbation and an improved pulmonary function in adults [42,43,44]. Similar conclusions were found also in three different pediatric studies by Kerely et al. and Majak et al. [45,46,47]. In addition, a brief review of several observational studies including both child and adult patients found that higher vitamin D levels were associated with a lower risk of acute asthma exacerbations [48,49].
Unfortunately, no uniform results have been obtained for vitamin D concentration and asthma control. While a positive relationship has been found between 25(OH)D level and childhood asthma control in some studies [31,50,51], no correlations between vitamin D concentrations and asthma control were noted in others [52,53,54]. While no correlations were found between allergic diseases and vitamin D level at the age of 9–12 years in the present study, low concentrations of vitamin D were found to be linked with wheezing and food allergy in the same population at the age of two years [46].
Vitamin E is a natural antioxidant found in large amounts in vegetables and fruits [55,56]. It has been found to play a crucial role in fetal lung development and vitamin E supplementation was associated with lower immunoglobulin E levels, suggesting a probable protective effect at the age of asthma onset [20]. The typical Western diet, low in natural antioxidants, has been linked with an increased incidence of asthma [56], and Misso et al. found low plasma vitamin E levels to be associated with worse lung function and increased severity of asthma symptoms [57]. In addition, Fogarty et al. indicate that vitamin E supplementation can reduce asthma severity and improve lung function [58]. A meta-analysis of observational studies found asthma to be related to vitamin A and C intake, but not vitamin E [59]. No correlations between atopy status and vitamin E were found in our previous study [59].
Our present findings do not indicate any correlations between antioxidant vitamins or micronutrients, and FEV1 and FVC. Although these findings may be due to the small sample size of asthma patients, they are consistent with those of other researchers [33,56].
Our study has some limitations. Firstly, the group sample is rather small, and secondly, the plasma concentrations of vitamins and microelements were measured at just one point of time (age 9–12 years); it would be interesting also to perform such an analysis for the whole period after birth. In addition, no data was obtained on the diet of the children, nor any micronutrient or vitamin supplementation nor the current nutritional status of the investigated patients. As only blood vitamin and micronutrient levels are included in the study, it is not possible to speculate on the reason for the low vitamin and micronutrient status of children. It seems also important to underline correlation does not necessarily imply a direct causal relationship.
Nevertheless, the key strength of the study is its diagnosis of allergic disease relying on both clinical assessment and evidence of allergic sensitization and assessment of skin-prick tests and pulmonary function tests; this allowed an objective outcome evaluation.

5. Conclusions

In conclusion, low concentrations of microelements, especially those of Cu and Zn, can influence the immune system, and may be considered as risk factors for the development of asthma, allergic rhinitis and food allergy.

Author Contributions

Conceptualization, M.B.-K.; Methodology, I.S.; Project administration, A.B.; Resources, K.S.; Supervision, J.J.; Writing—original draft, D.P.; Writing—review and editing, K.P. All authors have read and agreed to the published version of the manuscript.

Funding

The study was performed under the project supported by the grant from the National Science Center No. 2017/25/B/NZ5/02338 and from the National Science Center under the grant No. 2014/15/B/NZ7/00998, No. 2021/41/B/NZ7/0434.

Institutional Review Board Statement

The study was registered on: www.ClinicalTrials.gov, accessed on 12 December 2021, NCT01861548.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Martini, L.; Pecoraro, L.; Salvottini, C.; Piacentini, G.; Atkinson, R.; Pietrobelli, A. Appropriate and inappropriate vitamin sup-plementation in children. J. Nutr. Sci. 2020, 9, e20. [Google Scholar] [CrossRef] [PubMed]
  2. Pecora, F.; Persico, F.; Argentiero, A.; Neglia, C.; Esposito, S. The Role of Micronutrients in Support of the Immune Response against Viral Infections. Nutrients 2020, 12, 3198. [Google Scholar] [CrossRef] [PubMed]
  3. Wu, H.; Zhang, C.; Wang, Y.; Li, Y. Does vitamin E prevent asthma or wheeze in children: A systematic review and meta-analysis. Paediatr. Respir. Rev. 2018, 27, 60–68. [Google Scholar] [CrossRef] [PubMed]
  4. Kim, M.J.; Kim, S.N.; Lee, Y.W.; Choe, Y.B.; Ahn, K.J. Vitamin D Status and Efficacy of Vitamin D Supplementation in Atopic Dermatitis: A Systematic Review and Meta-Analysis. Nutrients 2016, 8, 789. [Google Scholar] [CrossRef]
  5. Stelmach, I.; Majak, P.; Jerzynska, J.; Podlecka, D.; Stelmach, W.; Polańska, K.; Gromadzińska, J.; Wąsowicz, W.; Hanke, W. Cord serum 25-hydroxyvitamin D correlates with early childhood viral-induced wheezing. Respir. Med. 2015, 109, 38–43. [Google Scholar] [CrossRef] [PubMed]
  6. Simon, D. Recent Advances in Clinical Allergy and Immunology 2019. Int. Arch. Allergy Immunol. 2019, 180, 291–305. [Google Scholar] [CrossRef]
  7. Halken, S. Prevention of allergic disease in childhood: Clinical and epidemiological aspects of primary and secondary allergy prevention. Pediatr. Allergy Immunol. 2004, 15 (Suppl. S16), 9–32. [Google Scholar] [CrossRef]
  8. Stelmach, I.; Grzelewski, T.; Bobrowska-Korzeniowska, M.; Kopka, M.; Majak, P.; Jerzynska, J.; Stelmach, W.; Polańska, K.; Sobala, W.; Gromadzińska, J.; et al. The role of zinc, copper, plasma glutathione peroxidase enzyme, and vitamins in the development of allergic diseases in early childhood: The Polish mother and child cohort study. Allergy Asthma Proc. 2014, 35, 227–232. [Google Scholar] [CrossRef]
  9. Bobrowska-Korzeniowska, M.; Jerzyńska, J.; Polańska, K.; Gromadzińska, J.; Hanke, W.; Wasowicz, W.; Stelmach, I. The role of antioxidants and 25-hydroxyvitamin D during pregnancy in the development of allergic diseases in early school-age children—Polish Mother and Child Cohort Study. Allergy Asthma Proc. 2020, 41, e19–e25. [Google Scholar] [CrossRef]
  10. Bobrowska-Korzeniowska, M.; Kapszewicz, K.; Jerzynska, J.; Stelmach, W.; Polanska, K.; Gromadzinska, J.; Mikolajewska, K.; Hanke, W.; Stelmach, I. Early life environmental exposure in relation to new onset and remission of allergic diseases in school children: Polish Mother and Child Cohort Study. Allergy Asthma Proc. 2019, 40, 329–337. [Google Scholar] [CrossRef]
  11. Shaheen, S.O.; Newson, R.B.; Henderson, A.J.; Emmett, P.M.; Sherriff, A.; Cooke, M.; ALSPAC Study Team. Umbilical cord trace elements and minerals and risk of early childhood wheezing and eczema. Eur. Respir. J. 2004, 24, 292–297. [Google Scholar] [CrossRef] [PubMed]
  12. Perisić, T.; Srećković, M.; Matić, G. An imbalance in antioxidant enzymes and stress proteins in childhood asthma. Clin. Biochem. 2007, 40, 1168–1171. [Google Scholar] [CrossRef] [PubMed]
  13. Kamer, B.; Wąsowicz, W.; Pyziak, K.; Kamer-Bartosińska, A.; Gromadzińska, J.; Pasowska, R. Role of selenium and zinc in the pathogenesis of food allergy in infants and young children. Arch. Med. Sci. 2012, 8, 1083–1088. [Google Scholar] [CrossRef] [PubMed]
  14. Liao, M.F.; Chen, C.C.; Hsu, M.H. Evaluation of the serum antioxidant status in asthmatic children. Acta Paediatr. Taiwan 2004, 45, 213–217. [Google Scholar] [PubMed]
  15. Bobrowska-Korzeniowska, M.; Brzozowska, A.; Jerzyńska, J.; Stelmach, W.; Stelmach, I. Usefulness of sRtot and Rint in bronchodilator testing in the diagnosis of asthma in children. Postepy Dermatol. Alergol. 2020, 37, 685–689. [Google Scholar] [CrossRef]
  16. Parsons, J.P.; Hallstrand, T.S.; Mastronarde, J.G.; Kaminsky, D.A.; Rundell, K.W.; Hull, J.H.; Storms, W.W.; Weiler, J.M.; Cheek, F.M.; Wilson, K.C.; et al. An official American Thoracic Society clinical practice guideline: Exercise-induced bronchoconstriction. Am. J. Respir. Crit. Care Med. 2013, 187, 1016–1027. [Google Scholar] [CrossRef]
  17. Agarwal, R.P.; Henkon, R.L. A simple method for simultaneous estimation of zinc and copper in erythrocytes. Biol. Trace Elem. Res. 1985, 7, 199–200. [Google Scholar] [CrossRef]
  18. Neve, J.; Chamart, S.; Molle, L. Optimization of a direct procedure for the determination of selenium in plasma and erythrocytes using Zeeman effect atomic absorption spectroscopy. Trace Elem. Anal. Chem. Med. Biol. 1987, 4, 349–358. [Google Scholar]
  19. Grzelinska, Z.; Gromadzinska, J.; Swiercz, R.; Wasowicz, W. Plasma concentration of vitamin E, vitamin A and β-carotene in healthy men. Polish J. Environ. Study 2007, 16, 209–213. [Google Scholar]
  20. Devereux, G.; Turner, S.W.; Craig, L.C.; McNeill, G.; Martindale, S.; Harbour, P.J.; Helms, P.J.; Seaton, A. Low maternal vitamin E intake during pregnancy is associated with asthma in 5-year-old children. Am. J. Respir. Crit. Care Med. 2006, 174, 499–507. [Google Scholar] [CrossRef]
  21. Stragierowicz, J.; Mikołajewska, K.; Zawadzka-Stolarz, M.; Polańska, K.; Ligocka, D. Estimation of cutoff values of cotinine in urine and saliva for pregnant women in Poland. BioMed Res. Int. 2013, 2013, 386784. [Google Scholar] [CrossRef] [PubMed]
  22. CDC. Available online: https://www.cdc.gov/nutrition/micronutrient-malnutrition/micronutrients/index.html (accessed on 12 December 2021).
  23. Zajac, D. Mineral Micronutrients in Asthma. Nutrients 2021, 13, 4001. [Google Scholar] [CrossRef] [PubMed]
  24. Alexander, J.; Tinkov, A.; Strand, T.A.; Alehagen, U.; Skalny, A.; Aaseth, J. Early Nutritional Interventions with Zinc, Selenium and Vitamin D for Raising Anti-Viral Resistance Against Progressive COVID-19. Nutrients 2020, 12, 2358. [Google Scholar] [CrossRef] [PubMed]
  25. Ariaee, N.; Farid, R.; Shabestari, F.; Shabestari, M.; Jabbari Azad, F. Trace elements status in sera of patients with allergic asthma. Rep. Biochem. Mol. Biol. 2016, 5, 20–25. [Google Scholar] [PubMed]
  26. Guo, C.H.; Liu, P.J.; Hsia, S.; Chuang, C.J.; Chen, P.C. Role of certain trace minerals in oxidative stress, inflammation, CD4/CD8 lymphocyte ratios and lung function in asthmatic patients. Ann. Clin. Biochem. 2011, 48, 344–351. [Google Scholar] [CrossRef] [PubMed]
  27. Hu, G.; Cassano, P. Antioxidants and pulmonary function: The third National Health and Nutrition Examination Survey (NHANES III). Am. J. Epidemiol. 2000, 151, 975–981. [Google Scholar] [CrossRef]
  28. Seaton, A.; Godden, D.J.; Brown, K. Increase in asthma: A more toxic environment or a more susceptible population? Thorax 1994, 49, 171–174. [Google Scholar] [CrossRef]
  29. Peroni, D.G.; Bonomo, B.; Casarotto, S.; Boner, A.L.; Piacentini, G.L. How changes in nutrition have influenced the development of allergic diseases in childhood. Ital. J. Pediatr. 2012, 38, 22. [Google Scholar] [CrossRef]
  30. Litonjua, A.A.; Rifas-Shiman, S.L.; Ly, N.P.; Tantisira, K.G.; Rich-Edwards, J.W.; Camargo CAJr Weiss, S.T.; Gillman, M.W.; Gold, D.R. Maternal antioxidant intake in pregnancy and wheezing illnesses in children at 2 y of age. Am. J. Clin. Nutr. 2006, 84, 903–911. [Google Scholar] [CrossRef]
  31. Uysalol, M.; Uysalol, E.P.; Yilmaz, Y.; Parlakgul, G.; Ozden, T.A.; Ertem, H.V.; Omer, B.; Uzel, N. Serum level of vitamin D and trace elements in children with recurrent wheezing: A cross-sectional study. BMC Pediatr. 2014, 14, 270. [Google Scholar] [CrossRef]
  32. Sagdic, A.; Sener, O.; Bulucu, F.; Karadurmus, N.; Ozel, H.E.; Yamanel, L.; Tasci, C.; Naharci, I.; Ocal, R.; Aydin, A. Oxidative stress status and plasma trace elements in patients with asthma or allergic rhinitis. Allergol. Immunopathol. 2011, 39, 200–205. [Google Scholar] [CrossRef] [PubMed]
  33. Moreno-Macias, H.; Romieu, I. Effects of antioxidant supplements and nutrients on patients with asthma and allergies. J. Allergy Clin. Immunol. 2014, 133, 1237–1244, quiz 1245. [Google Scholar] [CrossRef] [PubMed]
  34. Han, Y.Y.; Forno, E.; Holguin, F.; Celedón, J.C. Diet and asthma: An update. Curr. Opin. Allergy Clin. Immunol. 2015, 15, 369–374. [Google Scholar] [CrossRef] [PubMed]
  35. Gilliland, F.D.; Berhane, K.T.; Li, Y.F.; Gauderman, W.J.; McConnell, R.; Peters, J. Children’s lung function and antioxidant vitamin, fruit, juice and vegetable intake. Am. J. Epidemiol. 2003, 158, 576–584. [Google Scholar] [CrossRef] [PubMed]
  36. Harik-Khan, R.I.; Muller, D.C.; Wise, R.A. Serum vitamin levels and the risk of asthma in children. Am. J. Epidemiol. 2004, 159, 351–357. [Google Scholar] [CrossRef]
  37. Schwartz, J.; Weiss, S.T. Dietary factors and their relation to respiratory symptoms. The Second National Health and Nutrition Examination Survey. Am. J. Epidemiol 1990, 132, 67–76. [Google Scholar] [CrossRef]
  38. Chytil, F. The lungs and vitamin A. Am. J. Physiol. 1992, 262, L517–L527. [Google Scholar] [CrossRef]
  39. Kiraly, N.; Balde, A.; Lisse, I.M.; Eriksen, H.B.; Aaby, P.; Benn, C.S. Vitamin a supplementation and risk of atopy: Long-term follow-up of a randomized trial of vitamin a supplementation at six and nine months of age. BMC Pediatr. 2013, 13, 190. [Google Scholar] [CrossRef]
  40. Wang, M.; Liu, M.; Wang, C.; Xiao, Y.; An, T.; Zou, M.; Cheng, G. Association between vitamin D status and asthma control: A me-ta-analysis of randomized trials. Respir. Med. 2019, 150, 85–94. [Google Scholar] [CrossRef]
  41. Babar, M.Z.M.; Hussain, M.; Majeed, S.A. Vitamin D supplementation improves FEV1 in patients of bronchial asthma. Pak. J. Med. Sci. 2017, 33, 1144–1147. [Google Scholar]
  42. Martineau, A.R.; MacLaughlin, B.D.; Hooper, R.L.; Barnes, N.C.; Jolliffe, D.A.; Greiller, C.L.; Kilpin, K.; McLaughlin, D.; Fletcher, G.; Mein, C.A.; et al. Double-blind randomized placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax 2015, 70, 451–457. [Google Scholar] [CrossRef] [PubMed]
  43. de Groot, J.C.; van Roon, E.N.; Storm, H.; Veeger, N.J.; Zwinderman, A.H.; Hiemstra, P.S.; Bel, E.H.D.; Ten Brinke, A. Vitamin D reduces eosinophilic airway inflammation in nonatopic asthma. J. Allergy Clin. Immunol. 2015, 135, 670–675.e3. [Google Scholar] [CrossRef] [PubMed]
  44. Arshi, S.; Fallahpour, M.; Nabavi, M.; Bemanian, M.H.; Javad-Mousavi, S.A.; Nojomi, M.; Esmaeilzadeh, H.; Molatefi, R.; Rekabi, M.; Jalali, F.; et al. The effects of vitamin D supplementation on airway functions in mild to moderate persistent asthma. Ann. Allergy Asthma Immunol. 2014, 113, 404–409. [Google Scholar] [CrossRef] [PubMed]
  45. Kerley, C.P.; Hutchinson, K.; Cormican, L.; Faul, J.; Greally, P.; Coghlan, D.; Elnazir, B. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Pediatr. Allergy Immunol. 2016, 27, 404–412. [Google Scholar] [CrossRef]
  46. Majak, P.; Olszowiec-Chlebna, M.; Smejda, K.; Stelmach, I. Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. J. Allergy Clin. Immunol. 2011, 127, 1294–1296. [Google Scholar] [CrossRef]
  47. Majak, P.; Rychlik, B.; Stelmach, I. The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children. Clin. Exp. Allergy 2009, 39, 1830–1841. [Google Scholar] [CrossRef]
  48. Cassim, R.; Russell, M.A.; Lodge, C.J.; Lowe, A.J.; Koplin, J.J.; Dharmage, S.C. The role of circulating 25 hydroxyvitamin D in asthma: A systematic review. Allergy 2015, 70, 339–354. [Google Scholar] [CrossRef]
  49. Jat, K.R.; Khairwa, A. Vitamin D and asthma in children: A systematic review and meta-analysis of observational studies. Lung India 2017, 34, 355–363. [Google Scholar] [CrossRef]
  50. Gupta, A.; Sjoukes, A.; Richards, D.; Banya, W.; Hawrylowicz, C.; Bush, A.; Saglani, S. Relationship between serum Vitamin D, disease severity, and airway remodeling in children with asthma. Am. J. Respir. Crit. Care Med. 2011, 184, 1342–1349. [Google Scholar] [CrossRef]
  51. Chinellato, I.; Piazza, M.; Sandri, M.; Peroni, D.; Piacentini, G.; Boner, A.L. Vitamin D serum levels and markers of asthma control in Italian children. J. Pediatr. 2011, 158, 437–441. [Google Scholar] [CrossRef]
  52. Menon, J.; Maranda, L.; Nwosu, B.U. Serum 25-hydroxyvitamin D levels do not correlate with asthma severity in a case-controlled study of children and adolescents. J. Pediatr. Endocrinol. Metab. 2012, 25, 673–679. [Google Scholar] [CrossRef] [PubMed]
  53. Krobtrakulchai, W.; Praikanahok, J.; Visitsunthorn, N.; Vichyanond, P.; Manonukul, K.; Pratumvinit, B.; Jirapongsananuruk, O. The effect of vitamin d status on pediatric asthma at a university hospital, Thailand. Allergy Asthma Immunol. Res. 2013, 5, 289–294. [Google Scholar] [CrossRef] [PubMed]
  54. Neagu, F. Hypovitaminosis D is very frequent but not associated with asthmacontrol in a low-income pediatric population seen in an allergy and immunology clinic. J. Allergy Clin. Immunol. 2012, 129 (Suppl. S1), AB153. [Google Scholar] [CrossRef]
  55. Kelly, F.J.; Mudway, I.; Blomberg, A.; Frew, A.; Sandström, T. Altered lung antioxidant status in patients with mild asthma. Lancet 1999, 354, 482–483. [Google Scholar] [CrossRef]
  56. Wilkinson, M.; Hart, A.; Milan, S.J.; Sugumar, K. Vitamins C and E for asthma and exercise-induced bronchoconstriction. Cochrane Database Syst. Rev. 2014, 2014, CD010749. [Google Scholar] [CrossRef] [PubMed]
  57. Misso, N.L.A.; Brooks-Wildhaber, J.; Ray, S.; Vally, H.; Thompson, P.J. Plasma concentrations of dietary and non-dietary antioxidants are low in severe asthma. Eur. Respir. J. 2005, 26, 257–264. [Google Scholar] [CrossRef]
  58. Fogarty, A. Antioxidants and asthma: Will the patient benefit. Int. J. Tuberc. Lung Dis. 2012, 16, 1423. [Google Scholar] [CrossRef]
  59. Allen, S.; Britton, J.R.; Leonardi-Bee, J.A. Association between antioxidant vitamins and asthma outcome measures: Systematic review and meta-analysis. Thorax 2009, 64, 610. [Google Scholar] [CrossRef] [Green Version]
Table
Table 1. Characteristics of study group.
Table 1. Characteristics of study group.
VariableTotal
Group		AsthmaAllergic
Rhinitis		Atopic
Dermatitis		Food
Allergy		HDM
Allergy
n824141161420
Sex, female, n (%)47 (57.3)23 (56.1)24 (58.5)7 (43.8)6 (42.9)9 (45.0)
Age of mother, years, mean ± SD28.38 ± 4.4427.11 ± 4.3527.07 ± 4.7028.45 ± 4.4727.20 ± 3.4126.61 ± 3.16
BMI *, mean ± SD21.47 ± 3.8220.56 ± 4.0520.78 ± 4.2819.28 ± 5.4520.65 ± 2.2620.30 ± 1.81
Mother’s education, n (%)
≤9 years of education 12 (14.6)12 (29.3)11 (26.8)4 (25.0)4 (28.6)8 (40.0)
10–12 years of education21 (25.6)10 (24.4)9 (22.0)3 (18.8)1 (7.1)1 (5.0)
>12 years of education49 (59.8)19 (46.3)21 (51.2)9 (56.3)9 (64.3)11 (55.0)
Socio-economic status, n (%)
Modest38 (46.3)23 (56.1)20 (48.8)10 (62.5)10 (71.4)9 (45.0)
High44 (53.7)18 (43.9)21 (51.2)6 (37.5)4 (28.6)11 (55.0)
Parity, n (%)
044 (53.7)26 (63.4)26 (63.4)8 (50.0)6 (42.9)12 (60.0)
110 (12.2)10 (24.4)9 (22.0)3 (18.8)2 (14.3)5 (25.0)
>128 (34.1)5 (12.2)6 (14.6)5 (31.3)6 (42.9)3 (15.0)
Astma, n (%)41 (50.0)41 (100.0)35 (85.4)13 (81.3)11 (78.6)18 (90.0)
Allergic rhinitis, n (%)41 (50.0)35 (85.4)41 (100.0)8 (50.0)7 (50.0)19 (95.0)
Atopic dermatitis, n (%)16 (19.5)13 (31.7)8 (19.5)16 (100.0)9 (64.3)7 (35.0)
Food allergy, n (%)14 (17.1)11 (26.8)7 (17.1)9 (56.3)14 (100.0)7 (35.0)
HDM allergy, n (%)20 (24.4)18 (43.9)19 (46.3)7 (43.8)7 (50.0)20 (100.0)
Skin prick test, n (%)43 (52.4)36 (87.8)41 (100.0)9 (56.3)7 (50.0)20 (100.0)
Dampness, n (%)27 (32.9)22 (53.7)18 (43.9)10 (62.5)9 (64.3)17 (85.0)
Breastfed, n (%)82 (100.0)41 (100.0)41 (100.0)16 (100.0)14 (100.0)20 (100.0)
Pets, n (%)82 (100.0)41 (100.0)41 (100.0)16 (100.0)14 (100.0)20 (100.0)
Cotinine _child_urine_ng/mL, geometric mean ± SD1.88 ± 3.152.16 ± 3.432.06 ± 3.732.13 ± 1.851.70 ± 1.762.35 ± 3.24
FEV1% (B/P ^), mean ± SD101.93 ± 16.6196.79 ± 17.3296.65 ± 15.91108.43 ± 19.01105.96 ± 20.3399.82 ± 15.76
FVC% (B/P ^), mean ± SD92.46 ± 15.2592.27 ± 15.1491.14 ± 14.2198.92 ± 18.3095.38 ± 19.1794.46 ± 14.22
Se (µg/L), mean ± SD66.56 ± 11.7764.61 ± 12.8064.76 ± 12.4066.75 ± 14.7662.64 ± 12.6362.60 ± 12.55
Cu (mg/L) mean ± SD100.63 ± 17.4696.67 ± 17.4396.40 ± 18.80103.97 ± 13.45109.61 ± 12.0496.28 ± 17.61
Zn (mg/L) mean ± SD84.82 ± 15.6388.57 ± 18.0588.27 ± 14.7883.66 ± 23.6080.39 ± 16.5589.46 ± 18.29
Vit D 25 (ng/mL), mean ± SD22.43 ± 7.9423.28 ± 8.8723.48 ± 8.4521.87 ± 7.0022.78 ± 8.8623.56 ± 7.94
Vit D 1,25 (ng/mL), mean ± SD58.28 ± 20.0556.68 ± 21.9856.91 ± 18.8860.33 ± 26.0164.46 ± 25.5457.37 ± 20.79
Vit A (µg/mL), mean ± SD0.33 ± 0.110.31 ± 0.120.32 ± 0.130.34 ± 0.140.32 ± 0.080.33 ± 0.14
Vit E (µg/mL) mean ± SD9.40 ± 2.508.87 ± 2.148.93 ± 2.619.67 ± 2.0210.03 ± 1.899.27 ± 1.89
* BMI—Body mass index; HDM allergy—house dust mites’ allergy; ^ B/P—Best/Predicted value.
Table
Table 2. Comparison of blood concentrations of Zn, Se, Cu, vitamin D, vitamin A and vitamin E in patients with asthma, allergic rhinitis, atopic dermatitis, food allergy and HDM allergy.
Table 2. Comparison of blood concentrations of Zn, Se, Cu, vitamin D, vitamin A and vitamin E in patients with asthma, allergic rhinitis, atopic dermatitis, food allergy and HDM allergy.
Investigated TraitAllergy/Disease PresentAllergy/Disease Absentp
Mean ± SD95% CIRangeMean ± SD95% CIRange
Asthma
Se (µg/L)64.61 ± 12.8060.57–68.6538.00–91.0068.51 ± 10.4465.22–71.8153.00–94.000.135
Cu (mg/L)96.67 ± 17.4391.17–102.2061.20–131.70104.59 ± 16.7799.30–109.9065.40–133.600.039
Zn (mg/L)88.57 ± 18.0582.87–94.2758.10–147.6081.06 ± 11.8477.33–84.8062.20–106.000.029
Vit D 25 (ng/mL)23.28 ± 8.8720.48–26.077.80–52.8021.59 ± 6.9019.41–23.775.70–37.400.339
Vit D 1,25 (ng/mL)56.68 ± 21.9849.74–63.6227.80–134.3059.87 ± 18.0454.18–65.5731.50–114.400.475
Vit A (µg/mL)0.31 ± 0.120.27–0.350.14–0.640.35 ± 0.100.32–0.380.19–0.680.146
Vit E (µg/mL)8.87 ± 2.148.19–9.545.16–14.809.93 ± 2.739.07–10.794.44–19.040.053
Allergic rhinitis
Se (µg/L)64.76 ± 12.4060.84–68.6738.00–91.0068.37 ± 10.9764.90–71.8353.00–94.000.167
Cu (mg/L)96.40 ± 18.8090.46–102.3061.20–133.60104.86 ± 15.08100.10–109.6078.20–133.500.027
Zn (mg/L)88.27 ± 14.7883.60–92.9358.10–130.2081.37 ± 15.8876.35–86.3862.20–147.600.045
Vit D 25 (ng/mL)23.48 ± 8.4520.82–26.157.80–52.8021.38 ± 7.3519.06–23.705.70–37.400.233
Vit D 1,25 (ng/mL)56.91 ± 18.8850.95–62.8727.80–103.3059.65 ± 21.3052.93–66.3731.50–134.300.539
Vit A (µg/mL)0.32 ± 0.130.28–0.360.14–0.680.34 ± 0.100.31–0.370.19–0.630.318
Vit E (µg/mL)8.93 ± 2.618.11–9.765.16–19.049.87 ± 2.319.14–10.604.44–15.010.090
Atopic dermatitis
Se (µg/L)66.75 ± 14.7658.88–74.6238.00–94.0066.52 ± 11.0763.79–69.2440.00–91.000.953
Cu (mg/L)103.97 ± 13.4596.80–111.1080.70–131.7099.82 ± 18.3095.32–104.3061.20–133.600.314
Zn (mg/L)83.66 ± 23.6071.09–96.2458.10–147.6085.10 ± 13.2581.84–88.3663.00–130.200.817
Vit D 25 (ng/mL)21.87 ± 7.0018.14–25.607.80–35.8022.57 ± 8.2020.55–24.585.70–52.800.732
Vit D 1,25 (ng/mL)60.33 ± 26.0146.47–74.1927.80–134.3057.78 ± 18.5353.22–62.3429.80–114.400.715
Vit A (µg/mL)0.34 ± 0.140.27–0.410.15–0.640.33 ± 0.110.30–0.350.14–0.680.722
Vit E (µg/mL)9.67 ± 2.028.60–10.755.75–13.409.33 ± 2.618.70–9.974.44–19.040.571
Food allergy
Se (µg/L)62.64 ± 12.6355.35–69.9438.00–83.0067.37 ± 11.5264.58–70.1640.00–94.000.213
Cu (mg/L)109.61 ± 12.04102.70–116.6093.00–131.7098.78 ± 17.8994.45–103.1061.20–133.600.009
Zn (mg/L)80.39 ± 16.5570.84–89.9558.10–115.3085.73 ± 15.4182.00–89.4663.00–147.600.281
Vit D 25 (ng/mL)22.78 ± 8.8617.66–27.897.80–37.4022.36 ± 7.8120.47–24.255.70–52.800.872
Vit D 1,25 (ng/mL)64.46 ± 25.5449.71–79.2031.50–134.3057.01 ± 18.7052.48–61.5327.80–114.400.316
Vit A (µg/mL)0.32 ± 0.080.28–0.370.15–0.420.33 ± 0.120.30–0.360.14–0.680.758
Vit E (µg/mL)10.03 ± 1.898.93–11.126.94–14.529.27 ± 2.608.64–9.904.44–19.040.217
HDM allergy
Se (µg/L)62.60 ± 12.5556.73–68.4738.00–88.0067.84 ± 11.3264.96–70.7142.00–94.000.107
Cu (mg/L)96.28 ± 17.6188.04–104.5068.00–124.00102.03 ± 17.3297.64–106.4061.20–133.600.211
Zn (mg/L)89.46 ± 18.2980.90–98.0258.10–130.2083.32 ± 14.5379.63–87.0162.20–147.600.182
Vit D 25 (ng/mL)23.56 ± 7.9419.84–27.277.80–42.3022.07 ± 7.9720.04–24.095.70–52.800.473
Vit D 1,25 (ng/mL)57.37 ± 20.7947.63–67.1032.40–103.3058.57 ± 19.9753.50–63.6427.80–134.300.821
Vit A (µg/mL)0.33 ± 0.140.27–0.400.14–0.640.33 ± 0.100.30–0.360.19–0.680.938
Vit E (µg/mL)9.27 ± 1.898.39–10.165.35–13.409.44 ± 2.678.76–10.124.44–19.040.755
SD—standard deviation, CI—confidence interval. Groups with and without allergy/disease compared with independent t-test.
Table
Table 3. Logistic regression for occurrence of asthma, Allergic rhinitis, Atopic dermatitis, food allergy and HDM allergy.
Table 3. Logistic regression for occurrence of asthma, Allergic rhinitis, Atopic dermatitis, food allergy and HDM allergy.
Investigated TraitUnadjusted ModelsAdjusted Models *
OR95% CI for ORpORadj95% CI for ORadjpadj
Asthma
Se (µg/L)0.970.93–1.010.1360.970.93–1.020.221
Cu (mg/L)0.970.95–0.990.0430.970.94–1.0020.080
Zn (mg/L)1.041.004–1.070.0361.041.01–1.080.034
Vit D 25 (ng/mL)1.030.97–1.090.3371.020.96–1.090.436
Vit D 1,25 (ng/mL)0.990.97–1.010.4710.990.96–1.010.438
Vit A (µg/mL)0.050.01–2.600.1490.020.001–1.040.093
Vit E (µg/mL)0.830.67–1.090.0600.890.71–1.080.264
Allergic rhinitis
Se (µg/L)0.970.94–1.010.1670.970.93–1.020.266
Cu (mg/L)0.970.94–0.990.0310.970.94–1.0010.061
Zn (mg/L)1.0031.001–1.070.0531.031.01–1.070.059
Vit D 25 (ng/mL)1.040.98–1.100.2341.040.97–1.110.273
Vit D 1,25 (ng/mL)0.990.97–1.020.5350.990.97–1.020.502
Vit A (µg/mL)0.130.002–6.550.3150.080.001–5.470.257
Vit E (µg/mL)0.850.69–1.020.0960.900.73–1.090.305
Atopic dermatitis
Se (µg/L)1.0020.96–1.050.9431.010.96–1.060.786
Cu (mg/L)1.010.98–1.050.3931.020.99–1.060.262
Zn (mg/L)0.990.96–1.030.7410.990.95–1.030.811
Vit D 25 (ng/mL)0.990.92–1.060.7510.980.90–1.060.645
Vit D 1,25 (ng/mL)1.010.98–1.030.6471.0050.98–1.300.742
Vit A (µg/mL)2.810.02–298.440.6712.580.01–346.840.711
Vit E (µg/mL)1.060.84–1.300.6211.090.86–1.380.467
Food allergy
Se (µg/L)1.090.86–1.380.4670.970.91–1.020.234
Cu (mg/L)1.041.004–1.080.0401.051.01–1.110.020
Zn (mg/L)0.970.93–1.010.2440.980.93–1.020.424
Vit D 25 (ng/mL)1.010.93–1.080.8570.990.91–1.070.808
Vit D 1,25 (ng/mL)1.020.99–1.050.2111.020.99–1.050.202
Vit A (µg/mL)0.530.002–80.020.8120.240.001–61.180.638
Vit E (µg/mL)1.120.89–1.400.3061.21094–1.570.136
Separate models were prepared for each of response variables: asthma, allergic rhinitis, atopic dermatitis, food allergy and HDM allergy, *—models adjusted for: mother’s age, mother’s education, income, OR—odds ratio, CI—confidence interval.
Table
Table 4. Correlation between FEV1 and level of Zn, Se, Cu, vitamin D, vitamin A and vitamin E.
Table 4. Correlation between FEV1 and level of Zn, Se, Cu, vitamin D, vitamin A and vitamin E.
rp
Se (µg/L)−0.090.397
Cu (mg/L)−0.010.954
Zn (mg/L)−0.140.203
Vit D 25 (ng/mL)−0.070.537
Vit D 1,25 (ng/mL)0.060.574
Vit A (µg/mL)−0.090.410
Vit E (µg/mL)0.020.837
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Podlecka, D.; Jerzyńska, J.; Sanad, K.; Polańska, K.; Bobrowska-Korzeniowska, M.; Stelmach, I.; Brzozowska, A. Micronutrients and the Risk of Allergic Diseases in School Children. Int. J. Environ. Res. Public Health 2022, 19, 12187. https://doi.org/10.3390/ijerph191912187

AMA Style

Podlecka D, Jerzyńska J, Sanad K, Polańska K, Bobrowska-Korzeniowska M, Stelmach I, Brzozowska A. Micronutrients and the Risk of Allergic Diseases in School Children. International Journal of Environmental Research and Public Health. 2022; 19(19):12187. https://doi.org/10.3390/ijerph191912187

Chicago/Turabian Style

Podlecka, Daniela, Joanna Jerzyńska, Khadijah Sanad, Kinga Polańska, Monika Bobrowska-Korzeniowska, Iwona Stelmach, and Agnieszka Brzozowska. 2022. "Micronutrients and the Risk of Allergic Diseases in School Children" International Journal of Environmental Research and Public Health 19, no. 19: 12187. https://doi.org/10.3390/ijerph191912187

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop